posteditor

posteditor

Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting

B PITTSBURGH, May 1, 2026 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that six abstracts on its investigational low-dose estrogen combined… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

Lazard Reports First Quarter 2026 Results

B Campbell Lutyens acquisition will establish the leading global primary and secondary advisory business, with approximately $500 million in anticipated combined 2027 revenue Financial Advisory… Login to continue reading Login Sign up for complimentary access Sign Up Now Close